CN103860604A - Compound tablet containing kelp extract and cordyceps militaris - Google Patents
Compound tablet containing kelp extract and cordyceps militaris Download PDFInfo
- Publication number
- CN103860604A CN103860604A CN201310677736.8A CN201310677736A CN103860604A CN 103860604 A CN103860604 A CN 103860604A CN 201310677736 A CN201310677736 A CN 201310677736A CN 103860604 A CN103860604 A CN 103860604A
- Authority
- CN
- China
- Prior art keywords
- thallus
- cordyceps militaris
- extract
- thallus laminariae
- eckloniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001264174 Cordyceps militaris Species 0.000 title claims abstract description 34
- 150000001875 compounds Chemical class 0.000 title claims abstract description 13
- 241000512259 Ascophyllum nodosum Species 0.000 title abstract 8
- 239000000654 additive Substances 0.000 claims abstract description 11
- 230000000996 additive effect Effects 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 5
- 239000002131 composite material Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000013535 sea water Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 235000021110 pickles Nutrition 0.000 claims description 4
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 241001327634 Agaricus blazei Species 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 abstract description 12
- 229920001282 polysaccharide Polymers 0.000 abstract description 12
- 239000005017 polysaccharide Substances 0.000 abstract description 12
- 208000017169 kidney disease Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 3
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000000225 effect on diabetes Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 17
- 206010012601 diabetes mellitus Diseases 0.000 description 15
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 241001474374 Blennius Species 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 208000033679 diabetic kidney disease Diseases 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000009603 uroscopy Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a compound tablet containing a kelp extract and cordyceps militaris. The compound tablet comprises the following components in percentage by weight: 10-45% of the kelp extract, 10-45% of cordyceps militaris and 5-30% of an additive. A method for preparing the compound tablet containing kelp extract and cordyceps militaris comprises the following steps: (1) preparing the kelp extract; (2) adding cordyceps militaris into the kelp extract prepared in the step (1); and (3) adding the additive and tabletting a compound sugar-tablet. By extracting polysaccharide substances from kelp, the cordyceps militaris is added to form complex carbohydrate, so that the compound tablet has better treatment effect on diabetes and nephropathy then medicine only containing kelp extract or the cordyceps militaris. Based on effectively exerting the effect of two natural polysaccharides of algal polysaccharide and the cordyceps militaris, the compound tablet is formed through full and accurate experiments. The effect of the compound tablet is remarkably better than that of single prescription of the algal polysaccharide and the cordyceps militaris.
Description
Technical field
The present invention relates to the composite sheet of a kind of Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link..
Background technology
Along with growth in the living standard, all there is large variation in dietary structure and daily life system time, the people of diabetes, nephropathy of so-called " affluenza " is more and more, and diabetes, nephropathy are all to belong to chronic disease, need to take medicine for a long time, serious need to beat insulin or dialysis treatment, somewhat expensive.In long-term taking, the side effect wanted of west is obvious, patient takes medicine the function that can cause toleration or injure conversely kidney for a long time.Therefore in the urgent need to a kind of stand-by food or medicine that has mitigation to have no side effect to diabetes, nephropathy simultaneously.The food compound prescription of the low side effect of present stage to diabetes, nephropathy does not exist substantially.
Summary of the invention
Technical problem to be solved by this invention is: the composite sheet of a kind of Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link. is provided, is used for the treatment of diabetes, nephropathy.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
A composite sheet for Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link., is characterized in that, comprises the composition of following weight fraction: Thallus Laminariae (Thallus Eckloniae) extract 10-45%, Cordyceps militaris (L.) Link. 10-45%, additive 5-30%.
Preferably, additive is one or more in artificial Radix Ginseng, Concha Ostreae powder, Agaricus blazei Murrill dry powder.Additive can be used as filler, jointly makes composite sheet.
The method of preparing the composite sheet of Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link., comprises the following steps:
(
1) preparation of Thallus Laminariae (Thallus Eckloniae) extract: Thallus Laminariae (Thallus Eckloniae) weight in wet base 1000kg, without pulverizing or cutting into pieces, putting into sea water heats in the large-scale steamer of 85 degrees Celsius 1 minute, take out after Thallus Laminariae (Thallus Eckloniae), go with sea water is cold, in order to prevent that in Thallus Laminariae (Thallus Eckloniae), not overflowing of polysaccharide liquid stirred, add the neutral potassium salt that is equivalent to weight in wet base Thallus Laminariae (Thallus Eckloniae) 40%, pickle 24 hours, the raising of salinity in water, can cause that Thallus Laminariae (Thallus Eckloniae) cell wall acutely shrinks, secrete a large amount of humoral substances, centrifuge dewatering obtain 300 liters of liquid that contain Thallus Laminariae (Thallus Eckloniae) extract, then add water, alcohol precipitation obtain Thallus Laminariae (Thallus Eckloniae) extract
(2) in step (1), in the Thallus Laminariae (Thallus Eckloniae) extract of preparation, add Cordyceps militaris (L.) Link.,
(3) add additive, and be pressed into compound sugar-tablet.
Thallus Laminariae (Thallus Eckloniae) extract main component is as follows:
Fucoidin sulfate: 5%-40%
Fucoidin sulfate molecular weight at fucose molecular weight between 8000-400000 between 8000-400000
Micromolecule Algin: between 5%-25%
Micromolecule Algin: between 8000-2000000
Brown of light color.
The present invention, by after the extraction of polysaccharide material in Thallus Laminariae (Thallus Eckloniae), adds Cordyceps militaris (L.) Link., forms glycoconjugates, to the successful of diabetes, nephropathy, is better than independent use Thallus Laminariae (Thallus Eckloniae) extract or Cordyceps militaris (L.) Link.; The folk prescription that existing technology substantially all concentrates on algal polysaccharides, Cordyceps mycelium uses above, under the prerequisite of the food attribute that has kept pure natural, have no side effect, the successful of nephropathy and diabetes is better than to folk prescription.On the basis of this formula natural polysaccharide effect in effectively bringing into play seaweeds polysaccharide and Cordyceps militaris (L.) Link. two, form composite sheet by full and accurate experiment, its successful is better than the folk prescription of seaweeds polysaccharide and Cordyceps militaris (L.) Link..
Brief description of the drawings
Below in conjunction with accompanying drawing, the specific embodiment of the present invention is described in further detail.
Fig. 1 is that TK improves the heterophagous result figure of symptom to showing of diabetes rat (with matched group, P<0.05).
Fig. 2 is that TK affects result figure to the body weight of diabetes rat.
Fig. 3 is that TK slows down the result figure that increases blood glucose to diabetes rat.(*, with matched group, P <0.05)
Fig. 4 is that diabetes rat glycolated hemoglobin level is showing the result figure reducing, and TK group is than matched group (*, with matched group, P <0.05).
Fig. 5 is diabetes rat insulin secretion result figure, reduces at TK group (*, with matched group, P<0.05).
Fig. 6 is diabetes rat microdose urine protein/creatinine level result figure, and TK group is than matched group low (*, with matched group, P <0.05).
Fig. 7 is kidneys of diabetic rats section.
In figure, in bar diagram, the cylindricality of three comparisons is respectively from left to right control group, TK2% group, normal group.
Detailed description of the invention
Embodiment 1
A composite sheet for Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link., comprises the composition of following weight fraction: Thallus Laminariae (Thallus Eckloniae) extract 45%, Cordyceps militaris (L.) Link. 45%, and artificial Radix Ginseng 10%,
The method of preparing the composite sheet of Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link., comprises the following steps:
(
1) preparation of Thallus Laminariae (Thallus Eckloniae) extract: Thallus Laminariae (Thallus Eckloniae) weight in wet base 1000kg, without pulverizing or cutting into pieces, putting into sea water heats in the large-scale steamer of 85 degrees Celsius 1 minute, take out after Thallus Laminariae (Thallus Eckloniae), go with sea water is cold, in order to prevent that in Thallus Laminariae (Thallus Eckloniae), not overflowing of polysaccharide liquid stirred, add the neutral potassium salt that is equivalent to weight in wet base Thallus Laminariae (Thallus Eckloniae) 40%, pickle 24 hours, the raising of salinity in water, can cause that Thallus Laminariae (Thallus Eckloniae) cell wall acutely shrinks, secrete a large amount of humoral substances, centrifuge dewatering obtain 300 liters of liquid that contain Thallus Laminariae (Thallus Eckloniae) extract, then add water, alcohol precipitation obtain Thallus Laminariae (Thallus Eckloniae) extract
(2) in step (1), in the Thallus Laminariae (Thallus Eckloniae) extract of preparation, add Cordyceps militaris (L.) Link.,
(3) add additive, and be pressed into compound sugar-tablet.
Embodiment 2
A composite sheet for Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link., comprises the composition of following weight fraction: Thallus Laminariae (Thallus Eckloniae) extract 40%, Cordyceps militaris (L.) Link. 40%, and Concha Ostreae powder 10%, Agaricus blazei Murrill dry powder 10%,
The method of preparing the composite sheet of Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link., comprises the following steps:
1) preparation of Thallus Laminariae (Thallus Eckloniae) extract: Thallus Laminariae (Thallus Eckloniae) weight in wet base 1000kg, without pulverizing or cutting into pieces, putting into sea water heats in the large-scale steamer of 85 degrees Celsius 1 minute, take out after Thallus Laminariae (Thallus Eckloniae), go with sea water is cold, in order to prevent that in Thallus Laminariae (Thallus Eckloniae), not overflowing of polysaccharide liquid stirred, add the neutral potassium salt that is equivalent to weight in wet base Thallus Laminariae (Thallus Eckloniae) 40%, pickle 24 hours, the raising of salinity in water, can cause that Thallus Laminariae (Thallus Eckloniae) cell wall acutely shrinks, secrete a large amount of humoral substances, centrifuge dewatering obtain 300 liters of liquid that contain Thallus Laminariae (Thallus Eckloniae) extract, then add water, alcohol precipitation obtain Thallus Laminariae (Thallus Eckloniae) extract
(2) in step (1), in the Thallus Laminariae (Thallus Eckloniae) extract of preparation, add Cordyceps militaris (L.) Link.,
(3) add additive, and be pressed into compound sugar-tablet.
Embodiment 3 zooperies
As shown in Fig. 1-7, TK: the composite sheet that Thallus Laminariae (Thallus Eckloniae) extract, Cordyceps militaris (L.) Link. form.
Thallus Laminariae (Thallus Eckloniae) extract, pupa worm glycoconjugates grass can stimulating human islet cells line (RIN-5F) and Mice Islet Cells line MIN-6 excreting insulins.We sent out and can improve glycolated hemoglobin KK-Ay/Ta in rat blood afterwards, can be widely used in type 2 diabetes mellitus treatment.Select the rat of Spontaneous Diabetic (SDT); The obvious hyperglycemia of male SDT rat, polyuria, polydipsia, polyphagia, insulin level in blood and body weight all present downward trend gradually, and due to long-term hyperglycemia, SDT rat suffers from early diabetic nephropathy, diabetic peripheral neuropathy, diabetic retinopathy.
laboratory observation:
The foodstuff mixture of traditional standard, TK is in the concentration of 2%w/w, and since 100 week age to Oral Administration in Rats.Matched group gives common food does not have TK, and wild type SD rat is as Normal group.Survey weekly body weight, blood glucose, food intake dose and microdose urine protein/creatinine level, in serum insulin and blood, per fortnight of glycolated hemoglobin level measures once.In results in the end of the year, carry out nephridial tissue pathological examination.
Experiment conclusion
1.TK is the protection successful to glycolated hemoglobin, kidney in the anti-diabetic of SDT type ii diabetes rat model.The rat of 2.TK shows blood glucose and glycolated hemoglobin growth slowdown.3.SDT rat appetite is larger, and rear body weight increase in 15 weeks is very fast, and this shows that metabolism becomes worse.Than the not too not large variation of TK body weight, show to improve the metabolism of TK with common mouse.
The serum insulin of 4.SDT rat has fallen suddenly, reaches almost nil 18 week age and 20 weeks.5. before 18 weeks, the serum insulin of SDT and TK keeps normal, but starts at 20 weeks to decline.6. uroscopy is found, the diabetic nephropathy of SDT rat, 13 week age, belongs to early stage what test.And TK significantly suppresses nephropathy.
7.TK nephridial tissue pathology does not occur.
Claims (3)
1. a composite sheet for Thallus Laminariae (Thallus Eckloniae) extract and Cordyceps militaris (L.) Link., is characterized in that, comprises the composition of following weight fraction: Thallus Laminariae (Thallus Eckloniae) extract 10-45%, Cordyceps militaris (L.) Link. 10-45%, additive 5-30%.
2. the composite sheet of Thallus Laminariae (Thallus Eckloniae) extract according to claim 1 and Cordyceps militaris (L.) Link., is characterized in that, additive is one or more in artificial Radix Ginseng, Concha Ostreae powder, Agaricus blazei Murrill dry powder.
3. the method for the composite sheet of the Thallus Laminariae (Thallus Eckloniae) extract described in preparation claim 2 and Cordyceps militaris (L.) Link., is characterized in that, comprises the following steps:
(
1) preparation of Thallus Laminariae (Thallus Eckloniae) extract: Thallus Laminariae (Thallus Eckloniae) weight in wet base 1000kg, without pulverizing or cutting into pieces, putting into sea water heats in the large-scale steamer of 85 degrees Celsius 1 minute, take out after Thallus Laminariae (Thallus Eckloniae), go with sea water is cold, add the neutral potassium salt that is equivalent to weight in wet base Thallus Laminariae (Thallus Eckloniae) 40%, pickle 24 hours, centrifuge dewatering obtain 300 liters of liquid that contain Thallus Laminariae (Thallus Eckloniae) extract, then add water, alcohol precipitation obtain Thallus Laminariae (Thallus Eckloniae) extract;
(2) in step (1), in the Thallus Laminariae (Thallus Eckloniae) extract of preparation, add Cordyceps militaris (L.) Link.;
(3) add additive, and be pressed into compound sugar-tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310677736.8A CN103860604B (en) | 2013-12-13 | 2013-12-13 | Compound tablet containing kelp extract and cordyceps militaris |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310677736.8A CN103860604B (en) | 2013-12-13 | 2013-12-13 | Compound tablet containing kelp extract and cordyceps militaris |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103860604A true CN103860604A (en) | 2014-06-18 |
CN103860604B CN103860604B (en) | 2017-01-11 |
Family
ID=50899991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310677736.8A Expired - Fee Related CN103860604B (en) | 2013-12-13 | 2013-12-13 | Compound tablet containing kelp extract and cordyceps militaris |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103860604B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104083528A (en) * | 2014-07-20 | 2014-10-08 | 青岛昆布生物工程有限公司 | Brown seaweed and agaricus blazei murill compound tablet for improving human immunity and preparation method of compound tablet |
CN107050066A (en) * | 2017-02-14 | 2017-08-18 | 厦门华言科技有限公司 | Astaxanthin kelp self-emulsifying soft capsule and its preparation method and application |
CN107125753A (en) * | 2017-06-22 | 2017-09-05 | 烟台市芝罘区康华生物研究所 | A kind of golden cordyceps sinensis jelly fungi electuary |
CN107136281A (en) * | 2017-06-09 | 2017-09-08 | 清华大学 | It is a kind of to be used to improve kelp cordyceps sinensis pressed candy of women renal function and preparation method thereof |
CN107410642A (en) * | 2017-06-05 | 2017-12-01 | 清华大学 | It is a kind of to be used to improve kelp cordyceps sinensis pressed candy of male's renal function and preparation method thereof |
CN110354150A (en) * | 2019-06-19 | 2019-10-22 | 青岛昆布生物工程有限公司 | A kind of anti-chemotherapy brown alga composite sheet of service hoisting leucocyte |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1623423A (en) * | 2003-12-03 | 2005-06-08 | 王福来 | Method of preparing sodium algin jelly skin directly using kelp |
-
2013
- 2013-12-13 CN CN201310677736.8A patent/CN103860604B/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
徐雷雷: "《蛹虫草降血糖作用及其机制研究》", 《中国药理学通报》, vol. 27, no. 9, 30 September 2011 (2011-09-30), pages 1331 - 1332 * |
龙少华: "《海带面对糖尿病模型大鼠降糖作用的影响》", 《中国中医药信息杂志》, vol. 18, no. 6, 30 June 2011 (2011-06-30), pages 40 - 41 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104083528A (en) * | 2014-07-20 | 2014-10-08 | 青岛昆布生物工程有限公司 | Brown seaweed and agaricus blazei murill compound tablet for improving human immunity and preparation method of compound tablet |
CN107050066A (en) * | 2017-02-14 | 2017-08-18 | 厦门华言科技有限公司 | Astaxanthin kelp self-emulsifying soft capsule and its preparation method and application |
CN107410642A (en) * | 2017-06-05 | 2017-12-01 | 清华大学 | It is a kind of to be used to improve kelp cordyceps sinensis pressed candy of male's renal function and preparation method thereof |
CN107136281A (en) * | 2017-06-09 | 2017-09-08 | 清华大学 | It is a kind of to be used to improve kelp cordyceps sinensis pressed candy of women renal function and preparation method thereof |
CN107125753A (en) * | 2017-06-22 | 2017-09-05 | 烟台市芝罘区康华生物研究所 | A kind of golden cordyceps sinensis jelly fungi electuary |
CN110354150A (en) * | 2019-06-19 | 2019-10-22 | 青岛昆布生物工程有限公司 | A kind of anti-chemotherapy brown alga composite sheet of service hoisting leucocyte |
Also Published As
Publication number | Publication date |
---|---|
CN103860604B (en) | 2017-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860604B (en) | Compound tablet containing kelp extract and cordyceps militaris | |
CN102038720B (en) | Fuscoporia obliqua active ingredients capable of lowering blood sugar and preparation method and application of fuscoporia obliqua active ingredients | |
US10960044B2 (en) | Powder formulation having hypoglycemic and hypolipidemic functions and method for preparing the same | |
CN103070880B (en) | Application of acanthopanax trifoliatus polysaccharide in preparing medicine for treating diabetes | |
CN104491835A (en) | Assistant hypoglycemic health product containing Prunus padus L. polysaccharide | |
CN102552698A (en) | Medicinal application of dendrobium candidum | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
CN103655599B (en) | Polysaccharide composition and application, containing its pharmaceutical preparation | |
CN102813112B (en) | Foodstuff for diabetic nephropathy | |
CN103920135B (en) | A kind of Thallus Laminariae (Thallus Eckloniae) amino composite sheet reducing uric acid content and preparation method thereof | |
CN101559166B (en) | Ophiopogon japonicus extract, preparation method and hypoglycemic application thereof | |
CN105412222A (en) | Preparation method of sweet tea and cyclocarya paliurus composite original tea | |
CN105012826A (en) | Alpinia oxyphylla leaf extract and preparation method and application thereof | |
CN101406642B (en) | Antihypelipidemic compound formulation | |
CN104906145B (en) | Medical application of the Paecilomyces hepiali chen mutagenic strain PH40 in treatment diabetes | |
CN110974849B (en) | Compound sea cucumber extract with hypoglycemic activity and preparation method and application thereof | |
CN101406479A (en) | Double-melon antihypelipidemic composition | |
CN103989168B (en) | A kind of hypoglycemic composition | |
CN104940594A (en) | Application of brain preparation in the preparation of medicine for curing II-type diabetes mellitus and complications thereof | |
CN111543638A (en) | Sea cucumber polysaccharide product with auxiliary blood sugar reducing effect and preparation method thereof | |
CN111066728A (en) | Construction method of hyperglycemia animal model | |
CN105250339A (en) | Composition capable of decreasing blood sugar and preparation method thereof | |
CN105434886A (en) | Dendrobium officinale root extractive with blood-sugar reducing effect and uses thereof | |
CN102293817B (en) | Traditional Chinese medicine composition for reducing blood sugar and preparation method thereof | |
CN103599405B (en) | A kind of hypoglycemic medicine composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhao Yingwei Inventor after: Zhao Jien Inventor after: Xu Zuhong Inventor before: Zhao Yingwei Inventor before: Xu Ting |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170111 |